Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis

Abstract

Figures

Full text

Following publication of this article [1], the following errors were identified in Figs 3 and 6:

The revised Fig 3 is included with this Correction.

The corresponding author has provided a revised Fig 6 in which the incorrect AKT1 panel is replaced with the correct image from the original experiments and the corresponding Actin blots from the original experiments are also included. The revised Fig 6 also includes updated AKT/Actin ratios calculated in ImageJ for each AKT protein quantified against the correct corresponding Actin blot.

During editorial follow-up, the corresponding author provided the following additional information:

Supporting information

S1 FileOriginal images underlying Figs 5 and 6.Underlying image data for AKT1, C-Met and AKT2, and pAKT serine 473. Underlying image data for a repeat immunoblot of AKT2 from a different experiment completed during the same period.(ZIP)

S2 FileQuantitative data underlying Fig 6B.qRT-PCR analysis for AKT1 and AKT2.(XLSX)